FindTrial
Sign In

Study on the relationship between infant jaundice regression delay and 25- hydroxyvitamin D

Study on the relationship between infant jaundice regression delay and 25- hydroxyvitamin D

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099327
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice

Interventions

Observation group:None
Control group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 3 Months

Inclusion criteria

Inclusion criteria: 1. Observation group: Full-term infants, aged 1-3 months at the time of consultation, with a transcutaneous bilirubin measurement >5mg/dl at consultation. (2) Control group: Full-term infants, aged 1-3 months at the time of consultation, without jaundice at consultation.

Exclusion criteria

Exclusion criteria: 1.Newborns in both groups with critical congenital malformations. 2.Participants with unqualified samples, incomplete examination items, or whose family members refuse participation and request withdrawal from the study.

Design outcomes

Primary

MeasureTime frame
Two items related to vitamin D;Complication rate;Time to resolution of jaundice;Cost of treatment;—

Secondary

MeasureTime frame
Transcutaneous bilirubin measurement;—

Countries

China

Contacts

Public ContactWangcaifeng

Yuebei People’s Hospital

1781029185@qq.com+86 751 691 3517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026